Maxim Integrated Products (MXIM) 10-Q21 Apr 172017 Q3 Quarterly reportFinancial data

Company Profile

Document and Entity Information

Document and Entity Information Document - shares	9 Months Ended
Document and Entity Information Document - shares	Mar. 25, 2017	Apr. 17, 2017
DEI [Abstract]
Entity Registrant Name	MAXIM INTEGRATED PRODUCTS INC
Entity Central Index Key	743,316
Trading Symbol	MXIM
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Mar. 25, 2017
Document Fiscal Year Focus	2,017
Document Fiscal Period Focus	Q3
Current Fiscal Year End Date	--06-24
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		282,544,692

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 25, 2017	Jun. 25, 2016
Current assets:
Cash and cash equivalents	$ 1,656,727	$ 2,105,229
Short-term Investments	499,154	125,439
Total cash, cash equivalents and short-term investments	2,155,881	2,230,668
Accounts receivable, net	257,592	256,531
Inventories	241,439	227,929
Other assets current	60,195	91,920
Total current assets	2,715,107	2,807,048
Property, plant and equipment, net	636,835	692,551
Intangible assets, net	103,981	146,540
Goodwill	491,015	490,648
Other assets noncurrent	69,689	84,100
Assets Held-for-sale, Not Part of Disposal Group, Current	1,156	13,729
TOTAL ASSETS	4,017,783	4,234,616
Current liabilities:
Accounts payable	82,938	82,535
Income taxes payable	4,538	21,153
Accrued salary and related expenses	135,702	166,698
Accrued expenses	35,208	50,521
Deferred income on shipments to distributors	35,724	38,779
Short-term Debt	0	249,717
Total current liabilities	294,110	609,403
Long term debt	991,877	990,090
Income taxes payable	534,028	480,645
Other liabilities	37,459	46,664
Total liabilities	1,857,474	2,126,802
Commitments and contingencies (Note 11)
Stockholders' equity:
Common stock and capital in excess of par value	284	284
Retained earnings	2,169,760	2,121,749
Accumulated other comprehensive loss	(9,735)	(14,219)
Total stockholders' equity	2,160,309	2,107,814
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY	$ 4,017,783	$ 4,234,616

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheets Parenthetical - USD ($) $ in Thousands	Mar. 25, 2017	Jun. 25, 2016
Statement of Financial Position [Abstract]
Allowance for Doubtful Accounts Receivable, Current	$ 30,235	$ 32,108

Condensed Consolidated Statemen

Condensed Consolidated Statements of Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Income Statement [Abstract]
Net revenues	$ 581,216	$ 555,252	$ 1,693,610	$ 1,628,593
Cost of goods sold	214,312	236,411	640,796	731,232
Gross margin	366,904	318,841	1,052,814	897,361
Operating expenses:
Research and development	113,163	119,178	339,966	353,670
Selling, general and administrative	73,987	71,778	216,382	217,416
Amortization of Intangible Assets	2,348	2,538	7,139	9,667
Impairment of long-lived assets	1,000	506	7,517	160,153
Severance and Restructuring Charges	450	2,552	11,279	20,330
Other Operating Income (Expense), Net	1,704	(55,419)	(24,868)	(55,351)
Total operating expenses	192,652	141,133	557,415	705,885
Operating income	174,252	177,708	495,399	191,476
Interest and other expense, net	(3,884)	(6,373)	(11,390)	(22,368)
Income before provision for income taxes	170,368	171,335	484,009	169,108
Provision for income taxes	30,155	31,525	75,705	33,972
Net income	$ 140,213	$ 139,810	$ 408,304	$ 135,136
Earnings per share:
Basic (per share)	$ 0.50	$ 0.49	$ 1.44	$ 0.47
Diluted (per share)	$ 0.49	$ 0.48	$ 1.42	$ 0.47
Shares used in the calculation of earnings per share:
Basic (in shares)	282,903	285,854	283,348	285,323
Diluted (in shares)	287,882	289,783	288,209	289,648
Dividends paid per share	$ 0.33	$ 0.30	$ 0.99	$ 0.90

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Statements of Income and Comprehensive Income [Abstract]
Net income	$ 140,213	$ 139,810	$ 408,304	$ 135,136
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Net of Tax	349	265	(1,408)	(18)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Net of Tax	1,648	808	927	452
Unrealized gains (losses) on post-retirement benefits, net of tax benefit (expense)	59	172	4,965	516
Other Comprehensive Income (Loss), Net of Tax	2,056	1,245	4,484	950
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	142,269	141,055	412,788	136,086
Other Comprehensive Income (Loss), Unrealized Holding Gain (Loss) on Securities Arising During Period, Tax	349	265	(1,408)	(18)
Other Comprehensive Income (Loss), Unrealized Gain (Loss) on Derivatives Arising During Period, Tax	1,648	808	927	452
Other Comprehensive (Income) Loss, Pension and Other Postretirement Benefit Plans, Tax	$ 59	$ 172	$ 4,965	$ 516

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016
Cash flows from operating activities:
Net income	$ 408,304	$ 135,136
Adjustments to reconcile net income to net cash provided by operating activities:
Stock-based compensation	53,493	53,257
Depreciation and amortization	126,098	198,223
Deferred taxes	(9,592)	(34,628)
Loss on sale of property, plant and equipment	9,359	(2,765)
Gain (Loss) on Disposition of Business	(26,620)	(58,944)
Tax benefit (shortfall) related to stock-based compensation plans	0	3,718
Impairment of Long-Lived Assets to be Disposed of	797	160,153
Impairment of long-lived assets to be disposed of_investments in privately held companies	6,720	0
Excess tax benefit related to stock-based compensation	0	(7,660)
Changes in assets and liabilities:
Accounts receivable	(1,061)	342
Inventories	(15,500)	36,429
Other current assets and income tax refund receivable	(2,820)	(5,069)
Accounts payable	(970)	(8,752)
Income taxes payable	38,179	36,849
Deferred income on shipments to distributors	(3,055)	4,130
Increase (Decrease) in Employee Related Liabilities	(30,996)	(30,074)
All other accrued liabilities	(15,607)	(12,531)
Net cash provided by operating activities	536,729	467,814
Cash flows from investing activities:
Purchase of property, plant and equipment	(38,371)	(46,881)
Proceeds from sale of property, plant, and equipment	3,216	50,451
Proceeds from sale of available-for-sale securities	50,994	0
Proceeds from maturity of available-for-sale securities	25,000	0
Proceeds from Divestiture of Businesses	42,199	105,000
Payments to Acquire Available-for-sale Securities	(400,244)	(74,948)
Payments to Acquire Investments	(2,825)	(8,929)
Payments for (Proceeds from) Other Investing Activities	0	2,380
Net cash used in investing activities	(320,031)	27,073
Cash flows from financing activities:
Excess tax benefit related to stock-based compensation	0	7,660
Repayments of Notes Payable	(250,000)
Net issuance of restricted stock units	(17,713)	(21,397)
Proceeds from stock options exercised	44,568	67,336
Proceeds from Issuance of Shares under Incentive and Share-based Compensation Plans, Including Stock Options	14,464	14,350
Repurchase of common stock	(175,943)	(146,648)
Dividends paid	(280,576)	(256,813)
Net cash used in financing activities	(665,200)	(335,512)
Net decrease in cash and cash equivalents	(448,502)	159,375
Cash and cash equivalents:
Beginning of period	2,105,229	1,550,965
End of period	1,656,727	1,710,340
Supplemental disclosures of cash flow information:
Cash paid (refunded), net during the period for income taxes	57,952	26,927
Cash paid for interest	23,125	23,131
Noncash investing and financing activities:
Accounts payable related to property, plant, and equipment purchases	12,542	8,047
Proceeds from Sale of Other Property, Plant, and Equipment	$ 0	$ 40,000

Basis of Presentation

Basis of Presentation	9 Months Ended
Basis of Presentation	Mar. 25, 2017
Basis of Presentation [Abstract]
Basis of Presentation [Text Block]	BASIS OF PRESENTATION The accompanying unaudited condensed consolidated financial statements of Maxim Integrated Products, Inc. and all of its majority-owned subsidiaries (collectively, the “Company” or “Maxim Integrated”) included herein have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). Certain information and footnote disclosures normally included in consolidated financial statements prepared in accordance with generally accepted accounting principles of the United States of America (“GAAP”) have been condensed or omitted pursuant to applicable rules and regulations. In the opinion of management, all normal recurring adjustments which were considered necessary for fair statement have been included. The year-end condensed consolidated balance sheet data were derived from audited consolidated financial statements but do not include all disclosures required by GAAP. The results of operations for the nine months ended March 25, 2017 are not necessarily indicative of the results to be expected for the entire year. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and the notes thereto included in the Company's Annual Report on Form 10-K for the fiscal year ended June 25, 2016 . The Company has a 52-to-53-week fiscal year that ends on the last Saturday in June. Accordingly, every fifth or sixth fiscal year will be a 53-week fiscal year. Fiscal year 2016 was a 52-week fiscal year and fiscal year 2017 will also be a 52-week fiscal year.

Recently Issued Accounting Pron

Recently Issued Accounting Pronouncements	9 Months Ended
Recently Issued Accounting Pronouncements	Mar. 25, 2017
New Accounting Pronouncements and Changes in Accounting Principles [Abstract]
Recently Issued Accounting Pronouncements [Text Block]	RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS (i) New Accounting Updates Recently Adopted In March 2016, the FASB issued ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, which is intended to simplify several aspects of the accounting for share-based payment transactions, including the income tax consequences, classification of awards as either equity or liabilities, and classification on the statement of cash flows. The Company early adopted ASU 2016-09 at the beginning of the first quarter of fiscal year 2017. As a result of the adoption, in the first quarter of fiscal year 2017 the Company recorded a $1.4 million cumulative-effect adjustment to retained earnings for the recognition of excess tax benefits generated by the settlement of share-based awards in prior periods and a discrete income tax benefit of $3.3 million to the income tax provision for excess tax benefits generated by the settlement, in the first quarter of fiscal year 2017, of share-based awards. The adoption also resulted in an increase in cash flow from operating activities and a decrease in cash flow from financing activities of $3.3 million in the first quarter of fiscal year 2017. The adoption was on a prospective basis and therefore had no impact on prior periods. (ii) Recent Accounting Updates Not Yet Effective In May 2014, the FASB issued ASU No. 2014-09 , Revenue from Contracts with Customers (Topic 606) . This standard provides a single set of guidelines for revenue recognition to be used across all industries and requires additional disclosures. ASU No. 2014-09 is effective for the Company in the first quarter of fiscal year 2019 using either of two methods: (i) retrospective to each prior reporting period presented with the option to elect certain practical expedients as defined within ASU No. 2014-09; or (ii) retrospective with the cumulative effect of initially applying ASU No. 2014-09 recognized at the date of initial application and providing certain additional disclosures as defined per ASU No. 2014-09. Early adoption in the first quarter of fiscal year 2018 is permitted. The Company is currently evaluating the potential impact of this standard on its financial position and results of operations, as well as its selected transition method. In July 2015, the FASB issued ASU No. 2015-11, Inventory (Topic 330): Simplifying the Measurement of Inventory , which changes the measurement principle for inventory from the lower of cost or market to the lower of cost and net realizable value. ASU No. 2015-11 defines net realizable value as estimated selling prices in the ordinary course of business, less reasonably predictable costs of completion, disposal, and transportation. The new guidance must be applied on a prospective basis and is effective for the Company in the first quarter of fiscal year 2018, with early adoption permitted. The Company does not believe the implementation of this standard will result in a material impact to its consolidated financial statements. In January 2016, the FASB issued ASU 2016-01, Recognition and Measurement of Financial Assets and Financial Liabilities , which provides guidance for the recognition, measurement, presentation, and disclosure of consolidated financial assets and liabilities. This ASU will be effective for the Company beginning in the first quarter of fiscal year 2019. The application of this ASU will be by means of a cumulative-effect adjustment to the balance sheet. The amendments related to equity securities without readily determinable fair values (including disclosure requirements) will be applied prospectively to equity investments that exist as of the date of adoption. The Company is evaluating the effects of the adoption of this ASU on its consolidated financial statements. In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) , which supersedes the lease accounting requirements in Topic 840. ASU 2016-02 requires a dual approach for lessee accounting under which a lessee would account for leases as finance leases or operating leases. Both finance leases and operating leases will result in the lessee recognizing a right-of use asset and a corresponding lease liability. For finance leases, the lessee would recognize interest expense and amortization of the right-of-use asset, and for operating leases, the lessee would recognize a straight-line total lease expense. The guidance also requires qualitative and specific quantitative disclosures to supplement the amounts recorded in the financial statements so that users can understand more about the nature of an entity’s leasing activities, including significant judgments and changes in judgments. This guidance is effective beginning in the first quarter of fiscal year 2020 on a modified retrospective approach. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-04, Simplifying the Test for Goodwill Impairment (Topic 350) , which simplifies the measurement of goodwill impairment by removing the second step of the goodwill impairment test, which requires the determination of the fair value of individual assets and liabilities of a reporting unit. Under this guidance, goodwill impairment is to be measured as the amount by which a reporting unit’s carrying value exceeds its fair value with the loss recognized not to exceed the total amount of goodwill allocated to the reporting unit. The guidance is effective beginning in the first quarter of fiscal year 2021 on a prospective basis, with early adoption permitted for interim or annual goodwill impairment tests performed after January 1, 2017. The standard is to be applied on a prospective basis. The Company does not anticipate a material impact to the consolidated financial statements once implemented. In February 2017, the FASB issued ASU No. 2017-06, Plan Accounting: Defined Benefit Pension Plans (Topic 960); Defined Contribution Pension Plans (Topic 962); Health and Welfare Benefit Plans (Topic 965): Employee Benefit Plan Master Trust Reporting . This update provides guidance for reporting by an employee benefit plan for its interest in a master trust. The guidance is effective beginning in the first quarter of fiscal year 2021 on a retrospective basis, with early application permitted as of the beginning of the first quarter of fiscal year 2020. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements. In March 2017, the FASB issued ASU 2017-07, Improving the Presentation of Net Periodic Pension Cost and Net Periodic Postretirement Benefit Cost , which requires employers that offer or maintain defined benefit plans to disaggregate the service component from the other components of net benefit cost and provides guidance on presentation of the service component and the other components of net benefit cost in the statement of operations. The new standard is effective beginning in the third quarter of fiscal year 2018. The Company is currently evaluating the potential impact of this standard on its consolidated financial statements.

Balance Sheet Components

Balance Sheet Components	9 Months Ended
Balance Sheet Components	Mar. 25, 2017
Balance Sheet Related Disclosures [Abstract]
Balance Sheet Components [Text Block]	BALANCE SHEET COMPONENTS Inventories consist of: March 25, June 25, Inventories: (in thousands) Raw materials $ 10,762 $ 6,505 Work-in-process 149,007 148,762 Finished goods 81,670 72,662 $ 241,439 $ 227,929 Property, plant and equipment, net consists of: March 25, June 25, Property, plant and equipment, net: (in thousands) Land $ 18,952 $ 18,952 Buildings and building improvements 254,650 240,507 Machinery and equipment 1,349,101 1,370,322 1,622,703 1,629,781 Less: accumulated depreciation (985,868 ) (937,230 ) $ 636,835 $ 692,551 Accrued salary and related expenses consist of: March 25, June 25, Accrued salary and related expenses: (in thousands) Accrued vacation $ 28,527 $ 30,753 Accrued bonus 63,077 90,638 Accrued severance and post-employment benefits 10,697 14,230 Accrued salaries 7,924 14,320 Other 25,477 16,757 $ 135,702 $ 166,698

Fair Value Measurements

Fair Value Measurements	9 Months Ended
Fair Value Measurements	Mar. 25, 2017
Fair Value Disclosures [Abstract]
Fair Value Measurements [Text Block]	FAIR VALUE MEASUREMENTS The FASB established a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value. This hierarchy requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. Three levels of inputs that may be used to measure fair value are as follows: Level 1 - Quoted (unadjusted) prices in active markets for identical assets or liabilities. The Company’s Level 1 assets consist of money market funds. Level 2 - Observable inputs other than quoted prices included in Level 1, such as quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset or liability. The Company’s Level 2 assets and liabilities consist of U.S. treasury bills and foreign currency forward contracts that are valued using quoted market prices or are determined using a yield curve model based on current market rates. As a result, the Company has classified these investments as Level 2 in the fair value hierarchy. Also within Level 2 assets and liabilities are shares of common stock received as consideration for the sale of the Company's wafer manufacturing facility in San Antonio, Texas, which were valued based on quoted prices in the active market for identical assets, adjusted for estimated timing of sale. Level 3 - Unobservable inputs to the valuation methodology that are significant to the measurement of the fair value of the assets or liabilities. The Company did not hold any Level 3 assets or liabilities as of March 25, 2017 and June 25, 2016 . Assets and liabilities measured at fair value on a recurring basis were as follows: As of March 25, 2017 As of June 25, 2016 Fair Value Measurements Using Total Balance Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Money market funds (1) $ 1,133,416 $ — $ — $ 1,133,416 $ 1,658,321 $ — $ — $ 1,658,321 U.S. treasury bills (2) — 499,154 — 499,154 — 125,439 — 125,439 Foreign currency forward contracts (3) — 742 — 742 — 695 — 695 Investment in common stock (3) — — — — — 40,000 — 40,000 Total Assets $ 1,133,416 $ 499,896 $ — $ 1,633,312 $ 1,658,321 $ 166,134 $ — $ 1,824,455 Liabilities Foreign currency forward contracts (4) $ — $ 115 $ — $ 115 $ — $ 1,327 $ — $ 1,327 Total Liabilities $ — $ 115 $ — $ 115 $ — $ 1,327 $ — $ 1,327 (1) Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. (2) Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets. (3) Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets. (4) Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets. During the nine months ended March 25, 2017 and the year ended June 25, 2016 , there were no transfers in or out of Level 3 from other levels in the fair value hierarchy. There were no assets or liabilities measured at fair value on a non-recurring basis as of March 25, 2017 and June 25, 2016 other than impairments of Long-Lived assets. For details, please refer to Note 14: “Impairment of long-lived assets”.

Financial Instruments

Financial Instruments	9 Months Ended
Financial Instruments	Mar. 25, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments [Text Block]	FINANCIAL INSTRUMENTS Short-term investments Fair values were as follows: March 25, 2017 June 25, 2016 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments U.S. Treasury bills $ 500,073 $ — $ 919 $ 499,154 $ 124,950 $ 489 $ — $ 125,439 Total available-for-sale investments $ 500,073 $ — $ 919 $ 499,154 $ 124,950 $ 489 $ — $ 125,439 In the three and nine months ended March 25, 2017 and the year ended June 25, 2016 , the Company did not recognize any impairment charges on short-term investments. The U.S. Treasury bills have maturity dates between December 15, 2017 and June 15, 2019. Securities received as consideration for sale of assets During the third quarter of fiscal 2016, the Company received approximately $40.0 million in common shares of Tower Semiconductor Ltd. as consideration for the sale of the Company's semiconductor wafer manufacturing facility in San Antonio, Texas. During the six months ended December 24, 2016 , the Company sold all of these common shares for gross proceeds of approximately $51.0 million and recorded a realized gain of $5.0 million . The Company was required to return to Tower Semiconductor the first $6.0 million in gain realized upon the sale of such shares. As of March 25, 2017 , the Company has paid Tower Semiconductor $4.0 million and will pay the remaining $2.0 million during the fourth quarter of fiscal 2017. Derivative instruments and hedging activities The Company incurs expenditures denominated in non-U.S. currencies, primarily the Philippine Peso and the Thai Baht associated with the Company's manufacturing activities in the Philippines and Thailand, respectively, and the European Union Euro, South Korean Won, Japanese Yen and Chinese Yuan associated with expenditures for sales offices and research and development activities undertaken outside of the U.S. The Company has established a program that primarily utilizes foreign currency forward contracts to offset the risks associated with the effects of certain foreign currency exposures. The Company does not use these foreign currency forward contracts for trading purposes. Derivatives designated as cash flow hedging instruments The Company designates certain forward contracts as hedging instruments. As of March 25, 2017 and June 25, 2016 , the notional amounts of the forward contracts the Company held to purchase international currencies were $41.1 million and $68.0 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $1.4 million and $2.6 million , respectively. Derivatives not designated as hedging instruments As of March 25, 2017 and June 25, 2016 , the notional amounts of the forward contracts the Company held to purchase international currencies were $19.8 million and $25.4 million , respectively, and the notional amounts of forward contracts the Company held to sell international currencies were $16.9 million and $24.6 million , respectively. The fair values of our outstanding foreign currency forward contracts and related gain (loss) included in the Condensed Consolidated Statements of Income were not material for the three and nine months ended March 25, 2017 and the year ended June 25, 2016 . Long-term debt The following table summarizes the Company’s long-term debt: March 25, June 25, (in thousands) 2.5% fixed rate notes due November 2018 $ 500,000 $ 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Short-term credit agreement — 250,000 Total 1,000,000 1,250,000 Less: Current portion — (249,717 ) Less: Reduction for unamortized discount and debt issuance costs (8,123 ) (10,193 ) Total long-term debt $ 991,877 $ 990,090 On November 21, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 2.5% coupon senior unsecured and unsubordinated notes due in November 2018 (“2018 Notes”), with an effective interest rate of 2.6% . Interest on the 2018 Notes is payable semi-annually in arrears on May 15 and November 15 of each year, commencing on May 15, 2014. The net proceeds of this offering were approximately $494.5 million , after issuing at a discount and deducting paid expenses. On March 18, 2013, the Company completed a public offering of $500 million aggregate principal amount of the Company’s 3.375% senior unsecured and unsubordinated notes due in March 2023 (“2023 Notes”), with an effective interest rate of 3.5% . Interest on the 2023 Notes is payable semi-annually in arrears on March 15 and September 15 of each year. The net proceeds of this offering were approximately $490.0 million , after issuing at a discount and deducting paid expenses. The debt indentures that govern the 2023 Notes and the 2018 Notes, respectively, include covenants that limit the Company's ability to grant liens on its facilities and to enter into sale and leaseback transactions, which could limit the Company's ability to secure additional debt funding in the future. In circumstances involving a change of control of the Company followed by a downgrade of the rating of the 2023 Notes or the 2018 Notes, the Company would be required to make an offer to repurchase the affected notes at a purchase price equal to 101% of the aggregate principal amount of such notes, plus accrued and unpaid interest. The Company accounts for all the notes above based on their amortized cost. The discount and expenses are being amortized to Interest and other income (expense), net in the Condensed Consolidated Statements of Income over the life of the notes. The interest expense is recorded in Interest and other income (expense), net in the Condensed Consolidated Statements of Income. Amortized discount and expenses, as well as interest expense associated with the notes was $7.9 million and $7.8 million during the three months ended March 25, 2017 and March 26, 2016 , respectively. Amortized discount and expenses, as well as interest expense associated with the notes was $26.3 million and $23.5 million during the nine months ended March 25, 2017 and March 26, 2016 , respectively. The estimated fair value of the Company’s long-term debt was approximately $1,000 million as of March 25, 2017 . The estimated fair value of the debt is based primarily on observable market inputs and is a Level 2 measurement. The Company recorded interest expense of $8.1 million and $8.2 million during the three months ended March 25, 2017 , and March 26, 2016 , respectively. The Company recorded interest expense of $26.8 million and $24.5 million during the nine months ended March 25, 2017 , and March 26, 2016 , respectively. Credit Facility Revolving credit facility The Company has access to a $350 million senior unsecured revolving credit facility with certain institutional lenders that expires on June 27, 2019. The facility fee is at a rate per annum that varies based on the Company’s index debt rating and any advances under the credit agreement will accrue interest at a base rate plus a margin based on the Company’s index debt rating. The credit agreement requires the Company to comply with certain covenants, including a requirement that the Company maintain a ratio of debt to EBITDA (earnings before interest, taxes, depreciation, and amortization) of not more than 3 to 1 and a minimum interest coverage ratio (EBITDA divided by interest expense) greater than 3.5 to 1 . As of March 25, 2017 , the Company had not borrowed any amounts from this credit facility and was in compliance with all debt covenants. Short-term credit agreement On June 23, 2016, Maxim Holding Company Ltd., a wholly-owned foreign subsidiary of the Company, entered into a short-term credit agreement (the “Credit Agreement”) with The Bank of Tokyo-Mitsubishi UFJ, Ltd. (the “Lender”), in order to facilitate the return of capital to the Company. The Credit Agreement provides for, among other things, the Lender making an unsecured term loan in an amount equal to $250.0 million with a maturity date of June 22, 2017. The net proceeds of this Credit Agreement were approximately $249.7 million , after deducting paid issuance costs. The interest rate on the note was based on LIBOR plus a margin. The initial interest rate was 1.69% per annum and was adjusted quarterly. On December 21, 2016, the $250.0 million aggregate principal amount and all outstanding interest on the loan were repaid. Other Financial Instruments For the balance of the Company’s financial instruments, cash equivalents, accounts receivable, accounts payable and other accrued liabilities, the carrying amounts approximate fair value due to their short maturities.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
Stock-Based Compensation	Mar. 25, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock-Based Compensation [Text Block]	STOCK-BASED COMPENSATION At March 25, 2017 , the Company had one stock incentive plan, the Company's 1996 Stock Incentive Plan (the “1996 Plan”) and one employee stock purchase plan, the 2008 Employee Stock Purchase Plan (the “2008 ESPP”). The 1996 Plan was adopted by the Board of Directors to provide the grant of incentive stock options, non-statutory stock options, restricted stock units (“RSUs”), and performance shares, including market stock units (“MSUs”), to employees, directors, and consultants. Pursuant to the 1996 Plan, the exercise price for incentive stock options and non-statutory stock options is determined to be the fair market value of the underlying shares on the date of grant. Options typically vest ratably over a four-year period measured from the date of grant. Options generally expire no later than ten years after the date of grant, subject to earlier termination upon an optionee's cessation of employment or service. RSUs granted to employees typically vest ratably over a four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. MSUs granted to employees typically vest ratably over a two to four-year period and are converted into shares of the Company's common stock upon vesting, subject to the employee's continued service to the Company over that period. The number of shares that are released at the end of the performance period can range from zero to a maximum cap depending on the Company's performance. The performance metrics of this program are based on relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index XSD (the “SPDR S&P”). The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 25, 2017 and March 26, 2016 , respectively: Three Months Ended March 25, 2017 March 26, 2016 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 105 $ 1,660 $ 494 $ 2,259 $ 120 $ 1,182 $ 629 $ 1,931 Research and development 462 7,602 1,251 9,315 895 7,587 1,522 10,004 Selling, general and administrative 296 5,820 609 6,725 795 4,507 638 5,940 Pre-tax stock-based compensation expense $ 863 $ 15,082 $ 2,354 $ 18,299 $ 1,810 $ 13,276 $ 2,789 $ 17,875 Less: income tax effect 2,659 1,989 Net stock-based compensation expense $ 15,640 $ 15,886 Nine Months Ended March 25, 2017 March 26, 2016 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 440 $ 5,000 $ 1,491 $ 6,931 $ 735 $ 5,140 $ 1,808 $ 7,683 Research and development 1,305 22,293 3,536 27,134 2,608 20,671 3,904 27,183 Selling, general and administrative 1,115 16,557 1,756 19,428 2,415 14,271 1,705 18,391 Pre-tax stock-based compensation expense $ 2,860 $ 43,850 $ 6,783 $ 53,493 $ 5,758 $ 40,082 $ 7,417 $ 53,257 Less: income tax effect 8,551 8,046 Net stock-based compensation expense $ 44,942 $ 45,211 The expenses included in the Condensed Consolidated Statements of Income related to RSUs include expenses related to MSUs of $1.1 million and $0.7 million for the three months ended March 25, 2017 and March 26, 2016 , respectively and $2.5 million and $2.0 million for the nine months ended March 25, 2017 and March 26, 2016 , respectively. Stock Options There were no stock options granted in the three and nine months ended March 25, 2017 and three and nine months ended March 26, 2016 . The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 25, 2017 and their activity for the nine months ended March 25, 2017 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 25, 2016 5,935,079 $ 25.11 Options Granted — — Options Exercised (1,970,705 ) 22.61 Options Cancelled (351,285 ) 25.50 Balance at March 25, 2017 3,613,089 $ 26.26 2.6 $ 69,109,520 Exercisable, March 25, 2017 2,473,039 $ 25.27 2.3 $ 49,684,566 Vested and expected to vest, March 25, 2017 3,576,218 $ 26.23 2.6 $ 68,414,258 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 25, 2017. As of March 25, 2017 , there was $2.2 million of total unrecognized stock compensation cost related to 1.1 million unvested stock options, which is expected to be recognized over a weighted average period of approximately 0.7 years. Restricted Stock Units and Other Awards The fair value of RSUs and other awards under the Company’s 1996 Plan is estimated using the value of the Company’s common stock on the date of grant, reduced by the present value of dividends expected to be paid on the Company’s common stock prior to vesting. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. The weighted-average fair value of RSUs and other awards granted was $42.30 and $33.15 per share for the three months ended March 25, 2017 and March 26, 2016 , respectively and $37.02 and $29.25 per share for the nine months ended March 25, 2017 and March 26, 2016 , respectively. The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 25, 2017 and their activity during the nine months ended March 25, 2017 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 25, 2016 6,620,813 Restricted stock units and other awards granted 2,132,967 Restricted stock units and other awards released (1,380,533 ) Restricted stock units and other awards cancelled (743,139 ) Balance at March 25, 2017 6,630,108 2.8 $ 297,872,452 Outstanding and expected to vest, March 25, 2017 5,421,956 2.7 $ 245,939,941 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 25, 2017. The Company withheld shares totaling $8.3 million and $17.7 million in value as a result of employee withholding taxes based on the value of the RSUs on their vesting date for the three and nine months ended March 25, 2017 . The total payments for the employees’ tax obligations to the taxing authorities are reflected as financing activities within the Condensed Consolidated Statements of Cash Flows. As of March 25, 2017 , there was $147.8 million of unrecognized compensation expense related to 6.6 million unvested RSUs and other awards, which is expected to be recognized over a weighted average period of approximately 2.8 years. Market Stock Units The Company granted MSUs to senior members of management in September 2014, 2015 and 2016. The grant of MSUs was in lieu of granting stock options. MSUs are valued based on the relative performance of the Company’s stock price as compared to the Semiconductor Exchange Traded Fund index XSD (the “SPDR S&P”). The fair value of MSUs is estimated using a Monte Carlo simulation model on the date of grant. The Company also estimates forfeitures at the time of grant and makes revisions to forfeitures on a quarterly basis. Compensation expense is recognized based on the initial valuation and is not subsequently adjusted as a result of the Company’s performance relative to that of the XSD index. Vesting for MSUs is contingent upon both service and market conditions, and has a four-year vesting cliff period. There were no MSUs granted for the three months ended March 25, 2017 and March 26, 2016 . The weighted-average fair value of MSUs granted was $37.29 and $29.64 per share for the nine months ended March 25, 2017 and March 26, 2016 , respectively. The following table summarizes the number of MSUs outstanding and expected to vest as of March 25, 2017 and their activity during the nine months ended March 25, 2017 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 25, 2016 673,532 Market stock units granted 308,432 Market stock units released — Market stock units cancelled (128,520 ) Balance at March 25, 2017 853,444 2.9 $ 38,712,220 Outstanding and expected to vest, March 25, 2017 677,094 2.8 $ 30,712,962 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 25, 2017. As of March 25, 2017 , there was $17.8 million of unrecognized compensation expense related to 0.9 million unvested MSUs, which is expected to be recognized over a weighted average period of approximately 2.9 years. Employee Stock Purchase Plan Employees are granted rights to acquire common stock under the 2008 ESPP. The fair value of ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: ESPP ESPP Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, Expected holding period (in years) 0.5 0.5 0.5 0.5 Risk-free interest rate 0.5% 0.2% - 0.4% 0.5% - 0.7% 0.1% - 0.4% Expected stock price volatility 27.2% - 28.2% 24.2% - 33.1% 22.1% - 30.4% 21.8% - 33.1% Dividend yield 3.5% - 3.6% 3.3% - 3.6% 3.4% - 3.6% 3.3% - 3.6% As of March 25, 2017 and March 26, 2016 , there was $3.6 million and $4.7 million , respectively, of unrecognized compensation expense related to the 2008 ESPP.

Earnings Per Share

Earnings Per Share	9 Months Ended
Earnings Per Share	Mar. 25, 2017
Earnings Per Share [Abstract]
Earnings Per Share [Text Block]	EARNINGS (LOSS) PER SHARE Basic earnings (loss) per share are computed using the weighted average number of shares of common stock outstanding during the period. For purposes of computing basic earnings (loss) per share, the weighted average number of outstanding shares of common stock excludes unvested RSUs and MSUs. Diluted earnings (loss) per share incorporates the incremental shares issuable upon the assumed exercise of stock options, assumed release of unvested RSUs, Performance Shares, MSUs and assumed issuance of common stock under the 2008 ESPP using the treasury stock method. The following table sets forth the computation of basic and diluted earnings (loss) per share: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands, except per share data) Numerator for basic earnings (loss) per share and diluted earnings (loss) per share Net income (loss) $ 140,213 $ 139,810 $ 408,304 $ 135,136 Denominator for basic earnings (loss) per share 282,903 285,854 283,348 285,323 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 4,979 3,929 4,861 4,325 Denominator for diluted earnings (loss) per share 287,882 289,783 288,209 289,648 Earnings (loss) per share Basic $ 0.50 $ 0.49 $ 1.44 $ 0.47 Diluted $ 0.49 $ 0.48 $ 1.42 $ 0.47 For the three months ended March 25, 2017 and March 26, 2016 and the nine months ended March 25, 2017 and March 26, 2016 , no securities were determined to be anti-dilutive and therefore none were excluded from the calculation of diluted earnings per share.

Segment Information

Segment Information	9 Months Ended
Segment Information	Mar. 25, 2017
Segment Reporting [Abstract]
Segment Information [Text Block]	SEGMENT INFORMATION The Company designs, develops, manufactures and markets a broad range of linear and mixed signal integrated circuits. All of the Company's products are designed through a centralized R&D function, manufactured using centralized manufacturing (internal and external), and sold through a centralized sales force and shared wholesale distributors. one operating segment. In accordance with ASC No. 280, Segment Reporting (“ASC 280”), the Company considers operating segments to be components of the Company’s business for which separate financial information is available that is evaluated regularly by the Company’s Chief Operating Decision Maker in deciding how to allocate resources and in assessing performance. The Chief Operating Decision Maker for the Company was assessed and determined to be the CEO. The CEO reviews financial information presented on a consolidated basis for purposes of allocating resources and evaluating financial performance. Accordingly, the Company has determined that it has a single operating and reportable segment. Enterprise-wide information is provided in accordance with ASC 280. Geographical revenue information is based on customers’ ship-to location. Long-lived assets consist of property, plant and equipment. Property, plant and equipment information is based on the physical location of the assets at the end of each fiscal year. Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands) United States $ 65,698 $ 59,749 $ 199,234 $ 183,442 China 209,437 204,840 635,763 626,497 Rest of Asia 186,468 171,607 534,896 494,744 Europe 105,126 104,218 282,048 282,072 Rest of World 14,487 14,838 41,669 41,838 $ 581,216 $ 555,252 $ 1,693,610 $ 1,628,593 Net long-lived assets by geographic region were as follows: March 25, June 25, (in thousands) United States $ 392,869 $ 423,653 Philippines 133,309 141,569 Rest of World 110,657 127,329 $ 636,835 $ 692,551

Comprehensive Income Loss

Comprehensive Income Loss	9 Months Ended
Comprehensive Income Loss	Mar. 25, 2017
Statement of Comprehensive Income [Abstract]
Comprehensive Income [Text Block]	COMPREHENSIVE INCOME (LOSS) The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 25, 2017 and March 26, 2016 were as follows: (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 25, 2016 $ (6,280 ) $ (6,800 ) $ (1,136 ) $ (492 ) $ 489 $ (14,219 ) Other comprehensive income (loss) before reclassifications — 7,563 — (1,266 ) 3,043 9,340 Amounts reclassified out of accumulated other comprehensive loss (income) — 263 — 2,466 (4,451 ) (1,722 ) Tax effects — (2,861 ) — (273 ) — (3,134 ) Other comprehensive income (loss) — 4,965 — 927 (1,408 ) 4,484 March 25, 2017 $ (6,280 ) $ (1,835 ) $ (1,136 ) $ 435 $ (919 ) $ (9,735 ) (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 27, 2015 $ (6,280 ) $ (10,004 ) $ (1,136 ) $ 53 $ 133 $ (17,234 ) Other comprehensive income (loss) before reclassifications — — — (392 ) (18 ) (410 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 758 — 920 — 1,678 Tax effects — (242 ) — (76 ) — (318 ) Other comprehensive income (loss) — 516 — 452 (18 ) 950 March 26, 2016 $ (6,280 ) $ (9,488 ) $ (1,136 ) $ 505 $ 115 $ (16,284 )

Income Taxes

Income Taxes	9 Months Ended
Income Taxes	Mar. 25, 2017
Income Tax Disclosure [Abstract]
Income Taxes [Text Block]	INCOME TAXES In the three and nine months ended March 25, 2017 , the Company recorded an income tax provision of $30.2 million and $75.7 million , respectively, compared to $31.5 million and $34.0 million for the three and nine months ended March 26, 2016 , respectively. The Company’s effective tax rate for the three and nine months ended March 25, 2017 was 17.7% and 15.6% , respectively, compared to 18.4% and 20.1% for the three and nine months ended March 26, 2016 , respectively. The Company’s federal statutory tax rate is 35% . The Company’s effective tax rate for the three and nine months ended March 25, 2017 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, and a $4.3 million and $9.5 million of discrete excess tax benefits generated by the settlement of share-based awards in the three and nine months ended March 25, 2017 , respectively, partially offset by stock-based compensation for which no tax benefit is expected and $3.6 million and $10.4 million of discrete interest accruals for unrecognized tax benefits in the three and nine months ended March 25, 2017 , respectively. The Company's effective tax rate for the three months ended March 26, 2016 was lower than the statutory rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by stock-based compensation for which no tax benefit is expected and $20.4 million of non-deductible goodwill included in the sale of the energy metering business. The Company's effective tax rate for the nine months ended March 26, 2016 was lower than the statutory tax rate primarily due to earnings of foreign subsidiaries, generated primarily by the Company's international operations managed in Ireland, that were taxed at lower rates, partially offset by stock-based compensation for which no tax benefit is expected, $5.8 million of discrete interest accruals for unrecognized tax benefits and $20.4 million of non-deductible goodwill included in the sale of the energy metering business. The Company’s federal corporate income tax returns are audited on a recurring basis by the Internal Revenue Service (“IRS”). The IRS has concluded its field examination of the Company’s federal corporate income tax returns for fiscal years 2009 through 2011 and issued a IRS Revenue Agent's Report in July 2016 that includes proposed adjustments for transfer pricing issues related to cost sharing and buy-in license payments for the use of intangible property by one of the Company’s international subsidiaries. The Company disagrees with the proposed transfer pricing adjustments and related penalties, and in September 2016, the Company filed a protest to challenge the proposed adjustments and request a conference with the Appeals Office of the IRS. The Company believes that its reserves for unrecognized tax benefits are sufficient to cover any potential assessments that may result from the final resolution of these transfer pricing issues. In fiscal year 2017, the IRS commenced an audit of the Company’s federal corporate income tax returns for fiscal years 2012 through 2014, which is ongoing.

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
Commitments and Contingencies	Mar. 25, 2017
Product Warranties Disclosures [Abstract]
Commitments and Contingencies [Text Block]	COMMITMENTS AND CONTINGENCIES Legal Proceedings The Company is party or subject to various legal proceedings and claims, either asserted or unasserted, which arise in the ordinary course of business, including proceedings and claims that relate to intellectual property matters. While the outcome of these matters cannot be predicted with certainty, the Company does not believe that the outcome of any of these matters, individually or in the aggregate, will result in losses that are materially in excess of amounts already recognized or reserved, if any. Indemnification The Company indemnifies certain customers, distributors, suppliers and subcontractors for attorney fees, damages and costs awarded against such parties in certain circumstances in which the Company's products are alleged to infringe third party intellectual property rights, including patents, registered trademarks or copyrights. The terms of the Company's indemnification obligations are generally perpetual from the effective date of the agreement. In certain cases, there are limits on and exceptions to the Company's potential liability for indemnification relating to intellectual property infringement claims. Pursuant to the Company's charter documents and separate written indemnification agreements, the Company has certain indemnification obligations to its current officers, employees and directors, as well as certain former officers and directors. Product Warranty The changes in the Company’s aggregate product warranty liabilities for the nine months ended March 25, 2017 and March 26, 2016 were as follows: Nine Months Ended March 25, March 26, Product warranty liability (in thousands) Beginning balance 8,606 $ 13,436 Accruals for warranties 1,394 3,319 Payments (5,575 ) (9,047 ) Changes in estimate 877 903 Ending balance $ 5,302 $ 8,611 Less: Current portion 5,302 8,611 Non-current portion $ — $ —

Common Stock Repurchases

Common Stock Repurchases	9 Months Ended
Common Stock Repurchases	Mar. 25, 2017
Common Stock Repurchases [Abstract]
Common Stock Repurchases [Text Block]	COMMON STOCK REPURCHASES In July 2013, the Board of Directors authorized the Company to repurchase up to $1 billion of the Company’s common stock from time to time at the discretion of the Company’s management. This stock repurchase authorization has no expiration date. All prior authorizations by the Company’s Board of Directors for the repurchase of common stock were superseded by this authorization. During the nine months ended March 25, 2017 , the Company repurchased approximately 4.4 million shares of its common stock for $175.9 million . As of March 25, 2017 , the Company had remaining authorization of $153.8 million for future share repurchases. The number of shares to be repurchased and the timing of such repurchases will be based on several factors, including the price of the Company’s common stock and general market and business conditions.

Goodwill and Intangible Assets

Goodwill and Intangible Assets	9 Months Ended
Goodwill and Intangible Assets	Mar. 25, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Intangible Assets [Text Block]	GOODWILL AND INTANGIBLE ASSETS Goodwill The Company monitors the recoverability of goodwill recorded in connection with acquisitions, by reporting unit, annually, or more often if events or changes in circumstances indicate that the carrying amount may not be recoverable. No indicators or instances of impairment were identified in the nine months ended March 25, 2017 or during the fiscal year ended June 25, 2016 . Intangible Assets The useful lives of amortizable intangible assets are as follows: Asset Life Intellectual property 1-10 years Customer relationships 3-10 years Trade name 1-4 years Patents 5 years Intangible assets consisted of the following: March 25, June 25, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 451,885 $ 366,741 $ 85,144 $ 420,285 $ 331,321 $ 88,964 Customer relationships 115,634 98,293 17,341 115,634 92,744 22,890 Trade name 8,500 7,686 814 8,500 6,486 2,014 Patents 2,500 1,818 682 2,500 1,428 1,072 Total amortizable purchased intangible assets 578,519 474,538 103,981 546,919 431,979 114,940 IPR&D — — — 31,600 — 31,600 Total purchased intangible assets $ 578,519 $ 474,538 $ 103,981 $ 578,519 $ 431,979 $ 146,540 During the first quarter of fiscal year 2017, $31.6 million of IPR&D was completed and reclassified to amortizable Intellectual Property. The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands) Cost of goods sold $ 11,064 $ 11,829 $ 35,420 $ 43,201 Intangible asset amortization 2,348 2,538 7,139 9,667 Total intangible asset amortization expenses $ 13,412 $ 14,367 $ 42,559 $ 52,868 The following table represents the estimated future amortization expense of intangible assets as of March 25, 2017 : Fiscal Year Amount (in thousands) Remaining three months of 2017 $ 13,114 2018 48,146 2019 19,861 2020 9,942 2021 8,154 2022 2,563 Thereafter 2,201 Total intangible assets $ 103,981

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets (Notes)	9 Months Ended
Impairment of Long-Lived Assets (Notes)	Mar. 25, 2017
Property, Plant and Equipment Assets Held-for-sale Disclosure [Abstract]
Property, Plant and Equipment Disclosure [Text Block]	IMPAIRMENT OF LONG-LIVED ASSETS Fiscal year 2017: During the three and nine months ended March 25, 2017 , the Company recorded $1.0 million and $7.5 million , respectively, in impairment of long-lived assets in the Company’s Condensed Consolidated Statements of Income. The impairment was primarily associated with certain investments in privately held companies. The Company reached its conclusion regarding the asset impairment after the determination was made that due to factors during the nine months ended March 25, 2017 , the financial condition of the privately held companies indicated an other than temporary impairment. During the second quarter of fiscal year 2016, the Company classified the micro-electromechanical systems (MEMS) business line, including associated tangible assets and goodwill, as held for sale but no impairment charge was recorded as the carrying value of the product line's associated assets approximated or was less than the fair value, less cost to sell. The fair values of the assets were determined after consideration of quoted market prices of similar equipment and offers received. During the first quarter of fiscal year 2017, the Company completed the sale of this business line for approximately $42.2 million , resulting in a gain of $26.6 million , included in Other operating income (expenses), net, in the Condensed Consolidated Statements of Income. Fiscal year 2016: During the fiscal year ended June 25, 2016 , the Company recorded $160.6 million in impairment of long-lived assets in the Company's Consolidated Statements of Income. During the first quarter of fiscal year 2016, the Company recorded a $157.7 million impairment of long-lived assets associated with the Company's wafer manufacturing facility in San Antonio, Texas which was classified as held for sale and written down to fair value, less cost to sell. The Company reached its conclusion regarding the asset impairment after conducting an evaluation of assets' fair values. The fair value of the land, buildings and equipment was determined after consideration of expected discounted future cash flows attributable to the assets and outside appraisals. The Company signed an agreement with TowerJazz Texas, Inc. (formerly known as TJ Texas, Inc.), an indirect wholly-owned subsidiary of Tower Semiconductor Ltd. ("TowerJazz"), for the sale of the semiconductor wafer fabrication facility in San Antonio, Texas on November 18, 2015. During the third quarter of fiscal year 2016, the Company completed the sale of this facility for approximately $30.0 million in common shares of TowerJazz, resulting in a loss of $1.6 million included in Other operating income (expenses), net in the Condensed Consolidated Statements of Income. In addition, approximately $10.0 million in common shares of TowerJazz were received for the sale of the inventory on hand associated with this facility. In addition, the San Jose wafer fabrication facility was classified as held for sale during the first quarter of fiscal year 2016, but no impairment charge was recorded as the carrying value of the associated assets approximated the fair value, less cost to sell. The fair value of the land, buildings and equipment was determined after consideration of outside appraisals, quoted market prices of similar equipment and offers received. The Company completed the sale of this facility in the second quarter of fiscal year 2016 for approximately $39.0 million resulting in a gain of $3.8 million included in Other operating income (expenses), net in the Condensed Consolidated Statements of Income. During the second quarter of fiscal year 2016, the Company classified the energy metering business, including associated tangible and intangible assets and goodwill, as held for sale but no impairment charge was recorded as the carrying value of the product line's associated assets approximated or was less than the fair value, less cost to sell. The fair values of the assets were determined after consideration of offers received. During the third quarter of fiscal year 2016, the Company completed the sale of this product line for approximately $105.0 million , resulting in a gain of $58.9 million included in Other operating income (expenses), net in the Condensed Consolidated Statements of Income.

Restructuring Activities (Notes

Restructuring Activities (Notes)	9 Months Ended
Restructuring Activities (Notes)	Mar. 25, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Related Activities Disclosure [Text Block]	RESTRUCTURING ACTIVITIES Fiscal year 2017: During the three and nine months ended March 25, 2017 , the Company recorded $0.5 million and $11.3 million , respectively, in “Severance and restructuring expenses” in the Condensed Consolidated Statements of Income related to various restructuring plans designed to reduce costs. These charges were associated with continued reorganization of certain business units and functions and the closure of the Dallas wafer level packaging (“WLP”) manufacturing facilities. Multiple job classifications and locations were impacted by these activities. As the Company completed the closure of its Dallas, Texas campus, including ceasing operations of its WLP manufacturing facility in the third quarter of fiscal year 2017, the Company recorded accelerated depreciation charges of $1.1 million and $4.2 million during the three and nine months ended March 25, 2017 , respectively. Fiscal year 2016: San Jose Fab Shutdown In October 2014, the Company initiated a plan to shut down its San Jose wafer fabrication facility. The Company reached the decision that it was not economically feasible to maintain this facility, which was used primarily for fab process development and low volume manufacturing, as the Company intended to utilize other resources to complete such activities in the future. This plan included cash charges related to employee severance and non-cash charges related to accelerated depreciation. This plan has been completed, and the shutdown took place in the second quarter of fiscal year 2016. During the fiscal year ending June 25, 2016 , the Company recorded accelerated depreciation charges of $41.6 million , in “Cost of goods sold” and $0.4 million in “Severance and restructuring expenses” in the Consolidated Statements of Income. The sale of the San Jose wafer fabrication facility took place during the second quarter of fiscal year 2016. The cumulative costs recorded in fiscal year 2015 and 2016 to complete this restructuring plan were $100.3 million and no future restructuring costs associated with this plan are expected. Other Plans During the fiscal year ending June 25, 2016 , the Company recorded $24.0 million in “Severance and restructuring expenses” in the Consolidated Statements of Income related to various restructuring plans designed to reduce costs. These charges were associated with continued reorganization of certain business units and functions and the closure of the Dallas wafer level packaging (“WLP”) manufacturing facilities. Multiple job classifications and locations were impacted by these activities. As the Company had planned to close its Dallas, Texas campus, including its WLP manufacturing facility in fiscal year 2017, the Company recorded accelerated depreciation charges of $13.0 million during the fiscal year ending June 25, 2016 . Restructuring Accruals The Company has accruals for severance and restructuring payments within Accrued salary and related expenses in the accompanying Condensed Consolidated Balance Sheets. The following table summarizes changes in the accruals associated with these restructuring activities during the nine months ended March 25, 2017 : Balance, June 25, 2016 Nine Months Ended March 25, 2017 Balance, March 25, 2017 Charges Cash Payments Change in Estimates (in thousands) Severance - All plans (1) $ 7,578 $ 11,912 $ (13,829 ) $ (633 ) $ 5,028 (1) Charges and change in estimates are included in Severance and restructuring expenses in the accompanying Condensed Consolidated Statements of Income. Change in estimate: Due to the above mentioned restructuring activities, the Company recorded accelerated depreciation resulting from the change in estimated useful lives of certain long lived assets included in restructuring plans. In all periods that accelerated depreciation expense was recorded, this resulted in additional expense and therefore impacted operating income (loss), net income (loss) and earnings (loss) per share as presented in the table below. Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands, except per share data) Operating income (loss), as reported $ 174,252 $ 177,708 $ 495,399 $ 191,476 Operating income (loss), excluding accelerated depreciation expense 175,355 182,189 499,624 241,621 Effect of change in estimate $ (1,103 ) $ (4,481 ) $ (4,225 ) $ (50,145 ) Net income (loss), as reported $ 140,213 $ 139,810 $ 408,304 $ 135,136 Net income (loss), excluding accelerated depreciation expense 141,121 145,648 412,051 183,352 Effect of change in estimate $ (908 ) $ (5,838 ) $ (3,747 ) $ (48,216 ) Basic earnings (loss) per share, as reported $ 0.50 $ 0.49 $ 1.44 $ 0.47 Diluted earnings (loss) per share, as reported $ 0.49 $ 0.48 $ 1.42 $ 0.47 Basic earnings (loss) per share, excluding accelerated depreciation expense $ 0.50 $ 0.51 $ 1.45 $ 0.64 Diluted earnings (loss) per share, excluding accelerated depreciation expense $ 0.49 $ 0.50 $ 1.43 $ 0.63 Effect of change in estimate - basic earnings (loss) per share $ — $ (0.02 ) $ (0.01 ) $ (0.17 ) Effect of change in estimate - diluted earnings (loss) per share $ — $ (0.02 ) $ (0.01 ) $ (0.16 )

Balance Sheet Components (Table

Balance Sheet Components (Tables)	9 Months Ended
Balance Sheet Components (Tables)	Mar. 25, 2017
Balance Sheet Related Disclosures [Abstract]
Schedule of Inventory, Current [Table Text Block]	Inventories consist of: March 25, June 25, Inventories: (in thousands) Raw materials $ 10,762 $ 6,505 Work-in-process 149,007 148,762 Finished goods 81,670 72,662 $ 241,439 $ 227,929
Property, Plant and Equipment [Table Text Block]	Property, plant and equipment, net consists of: March 25, June 25, Property, plant and equipment, net: (in thousands) Land $ 18,952 $ 18,952 Buildings and building improvements 254,650 240,507 Machinery and equipment 1,349,101 1,370,322 1,622,703 1,629,781 Less: accumulated depreciation (985,868 ) (937,230 ) $ 636,835 $ 692,551
Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]	Accrued salary and related expenses consist of: March 25, June 25, Accrued salary and related expenses: (in thousands) Accrued vacation $ 28,527 $ 30,753 Accrued bonus 63,077 90,638 Accrued severance and post-employment benefits 10,697 14,230 Accrued salaries 7,924 14,320 Other 25,477 16,757 $ 135,702 $ 166,698

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	9 Months Ended
Fair Value Measurements (Tables)	Mar. 25, 2017
Fair Value Disclosures [Abstract]
Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]	Assets and liabilities measured at fair value on a recurring basis were as follows: As of March 25, 2017 As of June 25, 2016 Fair Value Measurements Using Total Balance Fair Value Measurements Using Total Level 1 Level 2 Level 3 Level 1 Level 2 Level 3 (in thousands) Assets Money market funds (1) $ 1,133,416 $ — $ — $ 1,133,416 $ 1,658,321 $ — $ — $ 1,658,321 U.S. treasury bills (2) — 499,154 — 499,154 — 125,439 — 125,439 Foreign currency forward contracts (3) — 742 — 742 — 695 — 695 Investment in common stock (3) — — — — — 40,000 — 40,000 Total Assets $ 1,133,416 $ 499,896 $ — $ 1,633,312 $ 1,658,321 $ 166,134 $ — $ 1,824,455 Liabilities Foreign currency forward contracts (4) $ — $ 115 $ — $ 115 $ — $ 1,327 $ — $ 1,327 Total Liabilities $ — $ 115 $ — $ 115 $ — $ 1,327 $ — $ 1,327 (1) Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets. (2) Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets. (3) Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets. (4) Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.

Financial Instruments (Tables)

Financial Instruments (Tables)	9 Months Ended
Financial Instruments (Tables)	Mar. 25, 2017
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Available-for-sale investments [Table Text Block]	Fair values were as follows: March 25, 2017 June 25, 2016 Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value Amortized Cost Gross Unrealized Gain Gross Unrealized Loss Estimated Fair Value (in thousands) Available-for-sale investments U.S. Treasury bills $ 500,073 $ — $ 919 $ 499,154 $ 124,950 $ 489 $ — $ 125,439 Total available-for-sale investments $ 500,073 $ — $ 919 $ 499,154 $ 124,950 $ 489 $ — $ 125,439
Schedule of long-term debt [Table Text Block]	The following table summarizes the Company’s long-term debt: March 25, June 25, (in thousands) 2.5% fixed rate notes due November 2018 $ 500,000 $ 500,000 3.375% fixed rate notes due March 2023 500,000 500,000 Short-term credit agreement — 250,000 Total 1,000,000 1,250,000 Less: Current portion — (249,717 ) Less: Reduction for unamortized discount and debt issuance costs (8,123 ) (10,193 ) Total long-term debt $ 991,877 $ 990,090

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
Stock-Based Compensation (Tables)	Mar. 25, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	The following tables show total stock-based compensation expense by type of award, and the resulting tax effect, included in the Condensed Consolidated Statements of Income for the three and nine months ended March 25, 2017 and March 26, 2016 , respectively: Three Months Ended March 25, 2017 March 26, 2016 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 105 $ 1,660 $ 494 $ 2,259 $ 120 $ 1,182 $ 629 $ 1,931 Research and development 462 7,602 1,251 9,315 895 7,587 1,522 10,004 Selling, general and administrative 296 5,820 609 6,725 795 4,507 638 5,940 Pre-tax stock-based compensation expense $ 863 $ 15,082 $ 2,354 $ 18,299 $ 1,810 $ 13,276 $ 2,789 $ 17,875 Less: income tax effect 2,659 1,989 Net stock-based compensation expense $ 15,640 $ 15,886 Nine Months Ended March 25, 2017 March 26, 2016 Stock Options Restricted Stock Units Employee Stock Purchase Plan Total Stock Options Restricted Stock Units Employee Stock Purchase Plan Total (in thousands) Cost of goods sold $ 440 $ 5,000 $ 1,491 $ 6,931 $ 735 $ 5,140 $ 1,808 $ 7,683 Research and development 1,305 22,293 3,536 27,134 2,608 20,671 3,904 27,183 Selling, general and administrative 1,115 16,557 1,756 19,428 2,415 14,271 1,705 18,391 Pre-tax stock-based compensation expense $ 2,860 $ 43,850 $ 6,783 $ 53,493 $ 5,758 $ 40,082 $ 7,417 $ 53,257 Less: income tax effect 8,551 8,046 Net stock-based compensation expense $ 44,942 $ 45,211
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding [Table Text Block]	The following table summarizes outstanding, exercisable and vested and expected to vest stock options as of March 25, 2017 and their activity for the nine months ended March 25, 2017 : Number of Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term (in Years) Aggregate Intrinsic Value (1) Balance at June 25, 2016 5,935,079 $ 25.11 Options Granted — — Options Exercised (1,970,705 ) 22.61 Options Cancelled (351,285 ) 25.50 Balance at March 25, 2017 3,613,089 $ 26.26 2.6 $ 69,109,520 Exercisable, March 25, 2017 2,473,039 $ 25.27 2.3 $ 49,684,566 Vested and expected to vest, March 25, 2017 3,576,218 $ 26.23 2.6 $ 68,414,258 (1) Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 25, 2017.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Restricted Stock Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the outstanding and expected to vest RSUs and other awards as of March 25, 2017 and their activity during the nine months ended March 25, 2017 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 25, 2016 6,620,813 Restricted stock units and other awards granted 2,132,967 Restricted stock units and other awards released (1,380,533 ) Restricted stock units and other awards cancelled (743,139 ) Balance at March 25, 2017 6,630,108 2.8 $ 297,872,452 Outstanding and expected to vest, March 25, 2017 5,421,956 2.7 $ 245,939,941 (1) Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 25, 2017.
Schedule of Share-based Compensation Arrangement by Share-based Payment Award, Performance-Based Units, Vested and Expected to Vest [Table Text Block]	The following table summarizes the number of MSUs outstanding and expected to vest as of March 25, 2017 and their activity during the nine months ended March 25, 2017 : Number of Shares Weighted Average Aggregate Intrinsic Value (1) Balance at June 25, 2016 673,532 Market stock units granted 308,432 Market stock units released — Market stock units cancelled (128,520 ) Balance at March 25, 2017 853,444 2.9 $ 38,712,220 Outstanding and expected to vest, March 25, 2017 677,094 2.8 $ 30,712,962 (1) Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 25, 2017.
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions [Table Text Block]	The fair value of ESPP rights granted to employees has been estimated at the date of grant using the Black-Scholes option valuation model using the following assumptions for the offering periods outstanding: ESPP ESPP Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, Expected holding period (in years) 0.5 0.5 0.5 0.5 Risk-free interest rate 0.5% 0.2% - 0.4% 0.5% - 0.7% 0.1% - 0.4% Expected stock price volatility 27.2% - 28.2% 24.2% - 33.1% 22.1% - 30.4% 21.8% - 33.1% Dividend yield 3.5% - 3.6% 3.3% - 3.6% 3.4% - 3.6% 3.3% - 3.6%

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
Earnings Per Share (Tables)	Mar. 25, 2017
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]	The following table sets forth the computation of basic and diluted earnings (loss) per share: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands, except per share data) Numerator for basic earnings (loss) per share and diluted earnings (loss) per share Net income (loss) $ 140,213 $ 139,810 $ 408,304 $ 135,136 Denominator for basic earnings (loss) per share 282,903 285,854 283,348 285,323 Effect of dilutive securities: Stock options, ESPP, RSUs, and MSUs 4,979 3,929 4,861 4,325 Denominator for diluted earnings (loss) per share 287,882 289,783 288,209 289,648 Earnings (loss) per share Basic $ 0.50 $ 0.49 $ 1.44 $ 0.47 Diluted $ 0.49 $ 0.48 $ 1.42 $ 0.47

Segment Information (Tables)

Segment Information (Tables)	9 Months Ended
Segment Information (Tables)	Mar. 25, 2017
Segment Reporting [Abstract]
Schedule of Revenue from External Customers by Geographical Areas [Table Text Block]	Net revenues from unaffiliated customers by geographic region were as follows: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands) United States $ 65,698 $ 59,749 $ 199,234 $ 183,442 China 209,437 204,840 635,763 626,497 Rest of Asia 186,468 171,607 534,896 494,744 Europe 105,126 104,218 282,048 282,072 Rest of World 14,487 14,838 41,669 41,838 $ 581,216 $ 555,252 $ 1,693,610 $ 1,628,593
Schedule of Long Lived Assets by Geographical Areas [Table Text Block]	Net long-lived assets by geographic region were as follows: March 25, June 25, (in thousands) United States $ 392,869 $ 423,653 Philippines 133,309 141,569 Rest of World 110,657 127,329 $ 636,835 $ 692,551

Comprehensive Income Loss (Tabl

Comprehensive Income Loss (Tables)	9 Months Ended
Comprehensive Income Loss (Tables)	Mar. 25, 2017
Statement of Comprehensive Income [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]	The changes in accumulated other comprehensive income (loss) by component and related tax effects in the nine months ended March 25, 2017 and March 26, 2016 were as follows: (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 25, 2016 $ (6,280 ) $ (6,800 ) $ (1,136 ) $ (492 ) $ 489 $ (14,219 ) Other comprehensive income (loss) before reclassifications — 7,563 — (1,266 ) 3,043 9,340 Amounts reclassified out of accumulated other comprehensive loss (income) — 263 — 2,466 (4,451 ) (1,722 ) Tax effects — (2,861 ) — (273 ) — (3,134 ) Other comprehensive income (loss) — 4,965 — 927 (1,408 ) 4,484 March 25, 2017 $ (6,280 ) $ (1,835 ) $ (1,136 ) $ 435 $ (919 ) $ (9,735 ) (in thousands) Unrealized Gains and Losses on Intercompany Receivables Unrealized Gains and Losses on Post-Retirement Benefits Cumulative Translation Adjustment Unrealized Gains and Losses on Cash Flow Hedges Unrealized Gains and Losses on Available-For-Sale Securities Total June 27, 2015 $ (6,280 ) $ (10,004 ) $ (1,136 ) $ 53 $ 133 $ (17,234 ) Other comprehensive income (loss) before reclassifications — — — (392 ) (18 ) (410 ) Amounts reclassified out of accumulated other comprehensive loss (income) — 758 — 920 — 1,678 Tax effects — (242 ) — (76 ) — (318 ) Other comprehensive income (loss) — 516 — 452 (18 ) 950 March 26, 2016 $ (6,280 ) $ (9,488 ) $ (1,136 ) $ 505 $ 115 $ (16,284 )

Commitments and Contingencies

Commitments and Contingencies (Tables)	9 Months Ended
Commitments and Contingencies (Tables)	Mar. 25, 2017
Product Warranties Disclosures [Abstract]
Schedule of Product Warranty Liability [Table Text Block]	The changes in the Company’s aggregate product warranty liabilities for the nine months ended March 25, 2017 and March 26, 2016 were as follows: Nine Months Ended March 25, March 26, Product warranty liability (in thousands) Beginning balance 8,606 $ 13,436 Accruals for warranties 1,394 3,319 Payments (5,575 ) (9,047 ) Changes in estimate 877 903 Ending balance $ 5,302 $ 8,611 Less: Current portion 5,302 8,611 Non-current portion $ — $ —

Goodwill and Intangible Assets

Goodwill and Intangible Assets (Tables)	9 Months Ended
Goodwill and Intangible Assets (Tables)	Mar. 25, 2017
Goodwill and Intangible Assets Disclosure [Abstract]
Useful lives of definite lived intangible assets [Table Text Block]	The useful lives of amortizable intangible assets are as follows: Asset Life Intellectual property 1-10 years Customer relationships 3-10 years Trade name 1-4 years Patents 5 years
Schedule of intangible assets [Table Text Block]	Intangible assets consisted of the following: March 25, June 25, Original Cost Accumulated Amortization Net Original Cost Accumulated Amortization Net (in thousands) Intellectual property $ 451,885 $ 366,741 $ 85,144 $ 420,285 $ 331,321 $ 88,964 Customer relationships 115,634 98,293 17,341 115,634 92,744 22,890 Trade name 8,500 7,686 814 8,500 6,486 2,014 Patents 2,500 1,818 682 2,500 1,428 1,072 Total amortizable purchased intangible assets 578,519 474,538 103,981 546,919 431,979 114,940 IPR&D — — — 31,600 — 31,600 Total purchased intangible assets $ 578,519 $ 474,538 $ 103,981 $ 578,519 $ 431,979 $ 146,540
Schedule of amortization expense allocation of intangible assets [Table Text Block]	The following table presents the amortization expense of intangible assets and its presentation in the Condensed Consolidated Statements of Income: Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands) Cost of goods sold $ 11,064 $ 11,829 $ 35,420 $ 43,201 Intangible asset amortization 2,348 2,538 7,139 9,667 Total intangible asset amortization expenses $ 13,412 $ 14,367 $ 42,559 $ 52,868
Estimated future amortization expense of intangible assets [Table Text Block]	The following table represents the estimated future amortization expense of intangible assets as of March 25, 2017 : Fiscal Year Amount (in thousands) Remaining three months of 2017 $ 13,114 2018 48,146 2019 19,861 2020 9,942 2021 8,154 2022 2,563 Thereafter 2,201 Total intangible assets $ 103,981

Restructuring Activities (Table

Restructuring Activities (Tables)	9 Months Ended
Restructuring Activities (Tables)	Mar. 25, 2017
Restructuring and Related Activities [Abstract]
Restructuring and Related Costs [Table Text Block]	The Company has accruals for severance and restructuring payments within Accrued salary and related expenses in the accompanying Condensed Consolidated Balance Sheets. The following table summarizes changes in the accruals associated with these restructuring activities during the nine months ended March 25, 2017 : Balance, June 25, 2016 Nine Months Ended March 25, 2017 Balance, March 25, 2017 Charges Cash Payments Change in Estimates (in thousands) Severance - All plans (1) $ 7,578 $ 11,912 $ (13,829 ) $ (633 ) $ 5,028 (1) Charges and change in estimates are included in Severance and restructuring expenses in the accompanying Condensed Consolidated Statements of Income.
Schedule of Change in Accounting Estimate [Table Text Block]	Due to the above mentioned restructuring activities, the Company recorded accelerated depreciation resulting from the change in estimated useful lives of certain long lived assets included in restructuring plans. In all periods that accelerated depreciation expense was recorded, this resulted in additional expense and therefore impacted operating income (loss), net income (loss) and earnings (loss) per share as presented in the table below. Three Months Ended Nine Months Ended March 25, March 26, March 25, March 26, (in thousands, except per share data) Operating income (loss), as reported $ 174,252 $ 177,708 $ 495,399 $ 191,476 Operating income (loss), excluding accelerated depreciation expense 175,355 182,189 499,624 241,621 Effect of change in estimate $ (1,103 ) $ (4,481 ) $ (4,225 ) $ (50,145 ) Net income (loss), as reported $ 140,213 $ 139,810 $ 408,304 $ 135,136 Net income (loss), excluding accelerated depreciation expense 141,121 145,648 412,051 183,352 Effect of change in estimate $ (908 ) $ (5,838 ) $ (3,747 ) $ (48,216 ) Basic earnings (loss) per share, as reported $ 0.50 $ 0.49 $ 1.44 $ 0.47 Diluted earnings (loss) per share, as reported $ 0.49 $ 0.48 $ 1.42 $ 0.47 Basic earnings (loss) per share, excluding accelerated depreciation expense $ 0.50 $ 0.51 $ 1.45 $ 0.64 Diluted earnings (loss) per share, excluding accelerated depreciation expense $ 0.49 $ 0.50 $ 1.43 $ 0.63 Effect of change in estimate - basic earnings (loss) per share $ — $ (0.02 ) $ (0.01 ) $ (0.17 ) Effect of change in estimate - diluted earnings (loss) per share $ — $ (0.02 ) $ (0.01 ) $ (0.16 )

Recently Issued Accounting Pr32

Recently Issued Accounting Pronouncements (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 24, 2016	Mar. 25, 2017	Mar. 26, 2016
New Accounting Pronouncement, Early Adoption [Line Items]
Cash flow from operating activities operating activities		$ 536,729	$ 467,814
Cash flow from financing activities		$ (665,200)	$ (335,512)
ASU 2016-09 [Member] \| Effect of Early Adoption of New Accounting Pronouncement [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Discrete income tax benefit generated by the settlement of share-based awards	$ 3,300
Cash flow from operating activities operating activities	3,300
Retained Earnings [Member] \| ASU 2016-09 [Member] \| Effect of Early Adoption of New Accounting Pronouncement [Member]
New Accounting Pronouncement, Early Adoption [Line Items]
Cumulative-effect adjustment	$ 1,400

Balance Sheet Components (Detai

Balance Sheet Components (Details) - USD ($) $ in Thousands	Mar. 25, 2017	Jun. 25, 2016
Inventories:
Raw materials	$ 10,762	$ 6,505
Work-in-process	149,007	148,762
Finished goods	81,670	72,662
Inventory, net	241,439	227,929
Property, plant and equipment:
Land	18,952	18,952
Buildings and building improvements	254,650	240,507
Machinery and equipment	1,349,101	1,370,322
Property, plant and equipment, gross	1,622,703	1,629,781
Less: accumulated depreciation and amortization	(985,868)	(937,230)
Property, plant and equipment, net	636,835	692,551
Employee-related Liabilities, Current [Abstract]
Accrued Vacation	28,527	30,753
Accrued Bonuses	63,077	90,638
Accrued severance and post-employment benefits	10,697	14,230
Accrued Salaries	7,924	14,320
Other	25,477	16,757
Accrued salary and related expenses	$ 135,702	$ 166,698

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands		6 Months Ended	9 Months Ended
Fair Value Measurements (Details) - USD ($) $ in Thousands		Dec. 24, 2016	Mar. 25, 2017	Mar. 26, 2016	Jun. 25, 2016	Jun. 27, 2015
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from sale of available-for-sale securities			$ 50,994	$ 0
Cash and cash equivalents			1,656,727	$ 1,710,340	$ 2,105,229	$ 1,550,965
Available-for-sale Securities			499,154		125,439
Fair Value, Measurements, Nonrecurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair Value, Assets and Liabilities Measured on Nonrecurring Basis		$ 0
Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0
Total Assets			1,633,312		1,824,455
Total Liabilities			115		1,327
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets			1,133,416		1,658,321
Total Liabilities			0		0
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets			499,896		166,134
Total Liabilities			115		1,327
Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total Assets			0		0
Total Liabilities			0		0
Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	[1]		1,133,416		1,658,321
Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	[1]		1,133,416		1,658,321
Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	[1]		0		0
Money Market Funds [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Cash and cash equivalents	[1]		0		0
US Treasury Securities [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	[2]		499,154		125,439
US Treasury Securities [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	[2]		0		0
US Treasury Securities [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	[2]		499,154		125,439
US Treasury Securities [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale Securities	[2]		0		0
Foreign Exchange Forward [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	[3]		742		695
Foreign currency forward contracts	[4]		115		1,327
Foreign Exchange Forward [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	[3]		0		0
Foreign currency forward contracts	[4]		0		0
Foreign Exchange Forward [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	[3]		742		695
Foreign currency forward contracts	[4]		115		1,327
Foreign Exchange Forward [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts	[3]		0		0
Foreign currency forward contracts	[4]		0		0
Certificates of Deposit [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts					70
Certificates of Deposit [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		0
Certificates of Deposit [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		70
Certificates of Deposit [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		0
Common Stock [Member] \| Fair Value, Measurements, Recurring [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		40,000
Common Stock [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		0
Common Stock [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			0		40,000
Common Stock [Member] \| Fair Value, Measurements, Recurring [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign currency forward contracts			$ 0		$ 0

[1]	Included in Cash and cash equivalents in the accompanying Condensed Consolidated Balance Sheets.
[2]	Included in Short-term investments in the accompanying Condensed Consolidated Balance Sheets.
[3]	Included in Other current assets in the accompanying Condensed Consolidated Balance Sheets.
[4]	Included in Accrued expenses in the accompanying Condensed Consolidated Balance Sheets.

Financial Instruments, Short-te

Financial Instruments, Short-term Investments (Details) - USD ($)	9 Months Ended	12 Months Ended
	Mar. 25, 2017	Jun. 25, 2016
Available-for-sale Securities [Abstract]
Amortized Cost	$ 500,073,000	$ 124,950,000
Gross Unrealized Gain	0	489,000
Gross Unrealized Loss	919,000	0
Estimated Fair Value	499,154,000	125,439,000
US Treasury Bills [Member]
Available-for-sale Securities [Abstract]
Amortized Cost	500,073,000	124,950,000
Gross Unrealized Gain	0	489,000
Gross Unrealized Loss	919,000	0
Estimated Fair Value	499,154,000	125,439,000
Short-Term Investment [Member]
Schedule of Available-for-sale Securities [Line Items]
Impairment charges	$ 0	$ 0

Financial Instruments Financial

Financial Instruments Financial Instruments, Securities Received as Consideration (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 25, 2017	Mar. 25, 2017	Mar. 26, 2016	Jun. 25, 2016
Investment [Line Items]
Shares received as consideration	$ 500,073	$ 500,073		$ 124,950
Proceeds from sale of shares		50,994	$ 0
Common Stock [Member]
Investment [Line Items]
Shares received as consideration			$ 40,000
Proceeds from sale of shares		51,000
Gross Unrealized Gain		5,000
Gain realized upon sale of shares, payable	6,000	6,000
Payment for gain on sale of available-for-sale securities	4,000
Gain on sale of available-for-sale securities, payable in the next six months	$ 2,000	$ 2,000

Financial Instruments, Balance

Financial Instruments, Balance Sheet Location (Details) - USD ($) $ in Millions	Mar. 25, 2017	Jun. 25, 2016
Derivatives designated as hedging instruments [Member] \| Cash Flow Hedging [Member] \| Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 41.1	$ 68
Derivatives designated as hedging instruments [Member] \| Cash Flow Hedging [Member] \| Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	1.4	2.6
Derivatives not designated as hedging instruments [Member] \| Forward contracts held to purchase U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	19.8	25.4
Derivatives not designated as hedging instruments [Member] \| Forward contracts held to sell U.S. dollars [Member]
Derivatives, Fair Value [Line Items]
Notional amount of derivatives	$ 16.9	$ 24.6

Financial Instruments, Long-ter

Financial Instruments, Long-term Debt (Details) - USD ($)	3 Months Ended		6 Months Ended		9 Months Ended
Financial Instruments, Long-term Debt (Details) - USD ($)	Mar. 25, 2017	Mar. 26, 2016	Dec. 24, 2016	Dec. 26, 2015	Mar. 25, 2017	Mar. 26, 2016	Dec. 21, 2016	Jun. 25, 2016	Dec. 28, 2013	Mar. 30, 2013
Debt Instrument [Line Items]
Long-term debt	$ 1,000,000,000				$ 1,000,000,000			$ 1,250,000,000
Short-term Debt, Fair Value	0				0		$ 250,000,000	250,000,000
Long-term debt, current portion	0				0			(249,717,000)
Debt Issuance Cost				$ (10,193,000)	(8,123,000)
Long-term debt, excluding current portion	991,877,000				991,877,000			$ 990,090,000
Stated interest rate of the notes								1.69%
Debt Instrument, Redemption Price, Percentage of Principal Amount Redeemed			101.00%
Interest expense relating to the Notes	7,900,000	$ 7,800,000			26,300,000	$ 23,500,000
Estimated fair value of long-term debt	1,000,000,000				1,000,000,000
Interest Expense	8,100,000	$ 8,200,000			26,800,000	$ 24,500,000
Fixed Rate Note Due November 2018 at 2 Point 50 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000,000				$ 500,000,000			$ 500,000,000	$ 500,000,000
Stated interest rate of the notes	2.50%				2.50%				2.50%
Effective interest rate of the Notes									2.60%
Net Proceeds From Issuance of Long Term Debt 4									$ 494,500,000
Fixed Rate Note Due March 2023 at 3 Point 375 Percent [Member]
Debt Instrument [Line Items]
Long-term debt	$ 500,000,000				$ 500,000,000			$ 500,000,000		$ 500,000,000
Stated interest rate of the notes	3.375%				3.375%					3.375%
Effective interest rate of the Notes										3.50%
Net Proceeds From Issuance of Long Term Debt 4										$ 490,000,000

Financial Instruments Financi39

Financial Instruments Financial Instruments, Credit Facility (Details)	9 Months Ended
	Mar. 25, 2017USD ($)	Dec. 21, 2016USD ($)	Jun. 25, 2016USD ($)
Debt Instrument [Line Items]
Short-term Debt, Fair Value	$ 0	$ 250,000,000	$ 250,000,000
Short-term Debt	0		$ 249,717,000
Stated interest rate of the notes			1.69%
Unsecured Revolving Credit Facility [Member]
Debt Instrument [Line Items]
Line of Credit Facility, Maximum Borrowing Capacity	$ 350,000,000
Debt Instrument, Covenant Requirement, Ratio of Debt to EBITDA	3
Debt Instrument, Convenant Requirement, minimum interest coverage ratio	3.5

Stock-Based Compensation (Detai

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 18,299	$ 17,875	$ 53,493	$ 53,257
Less: Income tax effect	2,659	1,989	8,551	8,046
Net stock-based compensation expense	15,640	15,886	44,942	45,211
Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,259	1,931	6,931	7,683
Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	9,315	10,004	27,134	27,183
General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	6,725	5,940	19,428	18,391
Stock options [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	863	1,810	2,860	5,758
Stock options [Member] \| Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	105	120	440	735
Stock options [Member] \| Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	462	895	1,305	2,608
Stock options [Member] \| General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 296	$ 795	$ 1,115	$ 2,415
Restricted stock units [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value	$ 42.30	$ 33.15	$ 37.02	$ 29.25
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 15,082	$ 13,276	$ 43,850	$ 40,082
Restricted stock units [Member] \| Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,660	1,182	5,000	5,140
Restricted stock units [Member] \| Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	7,602	7,587	22,293	20,671
Restricted stock units [Member] \| General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	5,820	4,507	16,557	14,271
ESP Plan [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	2,354	2,789	6,783	7,417
ESP Plan [Member] \| Cost of Sales [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	494	629	1,491	1,808
ESP Plan [Member] \| Research and Development Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	1,251	1,522	3,536	3,904
ESP Plan [Member] \| General and Administrative Expense [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	609	638	1,756	1,705
Market stock units [Member]
Share-based Compensation, Allocation and Classification in Financial Statements [Abstract]
Allocated Share-based Compensation Expense	$ 1,100	$ 700	$ 2,500	$ 2,000

Stock-Based Compensation, Fair

Stock-Based Compensation, Fair Value of Options (Details)	9 Months Ended
Stock-Based Compensation, Fair Value of Options (Details)	Mar. 25, 2017$ / shares
Stock options [Member]
Weighted-average Assumptions Used for Fair Value of Award Granted [Abstract]
Options granted, weighted average fair value of stock options (per share)	$ 0

Stock-Based Compensation, Stock

Stock-Based Compensation, Stock Option Plans (Details) - Stock options [Member]	9 Months Ended
	Mar. 25, 2017USD ($)$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Options outstanding, beginning	5,935,079
Options Granted	0
Options Exercised	(1,970,705)
Options Cancelled	(351,285)
Options outstanding, ending	3,613,089
Options exercisable, number of shares	2,473,039
Options vested and expected to vest, number of shares	3,576,218
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]
Options outstanding, weighted average exercise price, beginning (per share) \| $ / shares	$ 25.11
Options granted, weighted average exercise price (per share) \| $ / shares	0
Options exercised, weighted average exercise price (per share) \| $ / shares	22.61
Options cancelled, weighted average exercise price (per share) \| $ / shares	25.50
Options outstanding, weighted average exercise price, ending (per share) \| $ / shares	26.26
Options exercisable, weighted average exercise price (per share) \| $ / shares	25.27
Options vested and expected to vest, weighted average exercise price (per share) \| $ / shares	$ 26.23
Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]
Options outstanding, weighted average remaining contractual term (in years)	2 years 7 months 12 days
Options exercisable, weighted average remaining contractual term (in years)	2 years 3 months 12 days
Options vested and expected to vest, weighted average remaining contractual term (in years)	2 years 7 months 12 days
Options outstanding, aggregate intrinsic value \| $	$ 69,109,520	[1]
Options exercisable, aggregate intrinsic value \| $	49,684,566	[1]
Options vested and expected to vest, aggregate intrinsic value \| $	68,414,258	[1]
Unrecognized compensation costs related to unvested units \| $	$ 2,200,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares	1,100,000
Weighted average period of recognition for unrecognized compensation costs (in years)	8 months 24 days

[1]	(1)Aggregate intrinsic value represents the difference between the exercise price and the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of options outstanding, exercisable or vested and expected to vest as of March 25, 2017.

Stock-Based Compensation, Restr

Stock-Based Compensation, Restricted Stock Units (Details) - Restricted stock units [Member] - USD ($)		3 Months Ended		9 Months Ended
		Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (per share)		$ 42.30	$ 33.15	$ 37.02	$ 29.25
Outstanding and expected to vest RSUs [Roll Forward]
Outstanding, beginning				6,620,813
Granted				2,132,967
Released				(1,380,533)
Cancelled				(743,139)
Outstanding, ending		6,630,108		6,630,108
Expected to vest, number of shares		5,421,956		5,421,956
Outstanding, weighted average remaining contractual term (in years)				2 years 9 months 24 days
Restricted stock units vested and expected to vest, weighted average remaining contractual term 1				2 years 8 months 18 days
Outstanding, aggregate intrinsic value	[1]	$ 297,872,452		$ 297,872,452
Restricted stock units expected to vest, aggregate intrinsic value	[1]	245,939,941		245,939,941
Value of restricted stock unit shares withheld for withholding tax		8,300,000		17,700,000
Unrecognized compensation costs related to unvested units		$ 147,800,000		$ 147,800,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares		6,600,000		6,600,000
Weighted average period of recognition for unrecognized compensation costs (in years)				2 years 9 months 24 days

[1]	(1)Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 25, 2017.

Stock-Based Compensation Stock

Stock-Based Compensation Stock Based Compensation, Market Stock Units (Details) - USD ($)		3 Months Ended		9 Months Ended
		Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Restricted stock units [Member]
Outstanding and expected to vest MSUs [Roll Forward]
Weighted average grant date fair value (per share)		$ 42.30	$ 33.15	$ 37.02	$ 29.25
Outstanding, beginning				6,620,813
Granted				2,132,967
Released				(1,380,533)
Cancelled				(743,139)
Outstanding, ending		6,630,108		6,630,108
Expected to vest, number of shares		5,421,956		5,421,956
Outstanding, weighted average remaining contractual term (in years)				2 years 9 months 24 days
Outstanding, aggregate intrinsic value	[1]	$ 297,872,452		$ 297,872,452
Unrecognized compensation costs related to unvested units		$ 147,800,000		$ 147,800,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares		6,600,000		6,600,000
Weighted average period of recognition for unrecognized compensation costs (in years)				2 years 9 months 24 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value				$ 0
Market Stock Units [Member]
Outstanding and expected to vest MSUs [Roll Forward]
Weighted average grant date fair value (per share)				$ 37.29	$ 29.64
Outstanding, beginning				673,532
Granted				308,432
Released				0
Cancelled				(128,520)
Outstanding, ending		853,444		853,444
Expected to vest, number of shares		677,094		677,094
Outstanding, weighted average remaining contractual term (in years)				2 years 11 months 6 days
Outstanding and expected to Vest, weighted average remaining contractual term 3				2 years 10 months 6 days
Outstanding, aggregate intrinsic value	[2]	$ 38,712,220		$ 38,712,220
Outstanding and expected to vest, aggregate intrinsic value	[2]	30,712,962		30,712,962
Unrecognized compensation costs related to unvested units		$ 17,800,000		$ 17,800,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares		900,000		900,000
Weighted average period of recognition for unrecognized compensation costs (in years)				2 years 11 months 6 days

[1]	(1)Aggregate intrinsic value for RSUs and other awards represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of RSUs outstanding or expected to vest as of March 25, 2017.
[2]	(1)Aggregate intrinsic value for MSUs represents the closing price per share of the Company’s common stock on March 24, 2017, the last business day preceding the fiscal quarter-end, multiplied by the number of MSUs outstanding or expected to vest as of March 25, 2017.

Stock-Based Compensation, Emplo

Stock-Based Compensation, Employee Stock Purchase Plan (Details) - ESP Plan [Member] - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term	6 months		6 months	6 months
Unrecognized compensation costs related to unvested units	$ 3.6	$ 4.7	$ 3.6	$ 4.7
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.50%	0.20%	0.50%	10.00%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	27.20%	24.20%	22.10%	21.80%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.50%	3.30%	3.40%	3.30%
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.50%	0.40%	0.70%	0.40%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate	28.20%	33.10%	30.40%	33.10%
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate	3.60%	3.60%	3.60%	3.60%

Earnings Per Share (Details)

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Dec. 24, 2016	Mar. 25, 2017	Mar. 26, 2016
Numerator for basic earnings per share and diluted earnings per share
Net income	$ 140,213	$ 139,810		$ 408,304	$ 135,136
Denominator for basic earnings per share	282,903	285,854		283,348	285,323
Effect of dilutive securities
Stock options, ESPP and RSUs	4,979	3,929		4,861	4,325
Denominator for diluted earnings per share	287,882	289,783		288,209	289,648
Earnings per share, Basic (per share)	$ 0.50	$ 0.49		$ 1.44	$ 0.47
Earnings per share, Diluted	$ 0.49	$ 0.48		$ 1.42	$ 0.47
Antidilutive securities excluded from computation of earnings per share			0

Segment Information (Details)

Segment Information (Details) $ in Thousands	3 Months Ended		9 Months Ended
Segment Information (Details) $ in Thousands	Mar. 25, 2017USD ($)	Mar. 26, 2016USD ($)	Mar. 25, 2017USD ($)customers	Mar. 26, 2016USD ($)	Jun. 25, 2016USD ($)
Segment Reporting Information [Line Items]
Number of Reportable Segments \| customers			1
Revenues	$ 581,216	$ 555,252	$ 1,693,610	$ 1,628,593
Long-lived assets	636,835		636,835		$ 692,551
United States [Member]
Segment Reporting Information [Line Items]
Revenues	65,698	59,749	199,234	183,442
Long-lived assets	392,869		392,869		423,653
China [Member]
Segment Reporting Information [Line Items]
Revenues	209,437	204,840	635,763	626,497
Rest of Asia [Member]
Segment Reporting Information [Line Items]
Revenues	186,468	171,607	534,896	494,744
Europe [Member]
Segment Reporting Information [Line Items]
Revenues	105,126	104,218	282,048	282,072
Philippines [Member]
Segment Reporting Information [Line Items]
Long-lived assets	133,309		133,309		141,569
Rest of World [Member]
Segment Reporting Information [Line Items]
Revenues	14,487	$ 14,838	41,669	$ 41,838
Long-lived assets	$ 110,657		$ 110,657		$ 127,329

Comprehensive Income Loss Accum

Comprehensive Income Loss Accumulated Other Comprehensive Income (Loss) (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended	9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Dec. 26, 2015	Mar. 25, 2017	Mar. 26, 2016
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ (16,284)	$ (17,234)	$ (14,219)	$ (17,234)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(410)	9,340
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			1,678	(1,722)
Other Comprehensive Income (Loss), Tax			(318)	(3,134)
Other Comprehensive Income (Loss), Net of Tax	$ 2,056	1,245	950	4,484	950
Accumulated Other Comprehensive Income (Loss), Net of Tax	(9,735)		(16,284)	(9,735)
Unrealized Holding Gains (Losses) on Intercompany Receivables [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(6,280)	(6,280)	(6,280)	(6,280)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other Comprehensive Income (Loss), Net of Tax			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(6,280)		(6,280)	(6,280)
Accumulated Defined Benefit Plans Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(9,488)	(10,004)	(6,800)	(10,004)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	7,563
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			758	263
Other Comprehensive Income (Loss), Tax			(242)	(2,861)
Other Comprehensive Income (Loss), Net of Tax			516	4,965
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,835)		(9,488)	(1,835)
Accumulated Translation Adjustment [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		(1,136)	(1,136)	(1,136)	(1,136)
Other Comprehensive Income (Loss), before Reclassifications, before Tax			0	0
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	0
Other Comprehensive Income (Loss), Tax			0	0
Other Comprehensive Income (Loss), Net of Tax			0	0
Accumulated Other Comprehensive Income (Loss), Net of Tax	(1,136)		(1,136)	(1,136)
Accumulated Net Gain (Loss) from Designated or Qualifying Cash Flow Hedges [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		505	53	(492)	53
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(392)	(1,266)
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			920	2,466
Other Comprehensive Income (Loss), Tax			(76)	(273)
Other Comprehensive Income (Loss), Net of Tax			452	927
Accumulated Other Comprehensive Income (Loss), Net of Tax	435		505	435
Unrealized Holding Gains (losses) on Available-for-sale Investments [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Accumulated Other Comprehensive Income (Loss), Net of Tax		$ 115	133	489	$ 133
Other Comprehensive Income (Loss), before Reclassifications, before Tax			(18)	3,043
Reclassification from Accumulated Other Comprehensive Income, Current Period, before Tax			0	(4,451)
Other Comprehensive Income (Loss), Tax			0	0
Other Comprehensive Income (Loss), Net of Tax			(18)	(1,408)
Accumulated Other Comprehensive Income (Loss), Net of Tax	$ (919)		$ 115	$ (919)

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
Income Taxes (Details) - USD ($) $ in Thousands	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Income Tax Disclosure [Abstract]
Provision for income taxes	$ 30,155	$ 31,525	$ 75,705	$ 33,972
Effective Income Tax Rate Reconciliation, Percent	17.70%	18.40%	15.60%	20.10%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent	0.00%
Tax credit, foreign, amount	$ 4,300		$ 9,500
Unrecognized Tax Benefits, Interest on Income Taxes Accrued	$ 10,400	$ 5,800	$ 10,400	$ 5,800
Effective Income Tax Rate Reconciliation, Disposition of Business, Amount		$ 20,400		$ 20,400

Commitments and Contingencies (

Commitments and Contingencies (Details) - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
	Mar. 25, 2017	Mar. 25, 2017	Mar. 26, 2016
Movement in Standard and Extended Product Warranty, Increase (Decrease) [Roll Forward]
Product Warranty Accrual		$ 8,606	$ 13,436
Product Warranty Accrual, Warranties Issued	$ 1,394		3,319
Product Warranty Accrual, Payments	(5,575)		(9,047)
Product Warranty Accrual, Preexisting, Increase (Decrease)		877	903
Product Warranty Accrual	5,302	5,302	8,611
Product Warranty Accrual, Current	5,302	5,302	8,611
Product Warranty Accrual, Noncurrent	$ 0	$ 0	$ 0

Common Stock Repurchases (Detai

Common Stock Repurchases (Details) - USD ($) shares in Millions, $ in Millions	9 Months Ended
	Mar. 25, 2017	Jul. 31, 2013
Common Stock Repurchases [Abstract]
Stock repurchase program, authorized amount		$ 1,000
Shares of common stock repurchased	4.4
Value of common stock repurchased	$ 175.9
Stock repurchase program, remaining authorized amount	$ 153.8

Goodwill and Intangible Asset52

Goodwill and Intangible Assets Useful Lives of Amortizable Intangible Assets (Details)	9 Months Ended
	Mar. 25, 2017
Intellectual property [Member] \| Minimum [Member]
Amortizable intangible assets, useful life, minimum (in years)	1 year
Intellectual property [Member] \| Maximum [Member]
Amortizable intangible assets, useful life, minimum (in years)	10 years
Customer relationships [Member] \| Minimum [Member]
Amortizable intangible assets, useful life, minimum (in years)	3 years
Customer relationships [Member] \| Maximum [Member]
Amortizable intangible assets, useful life, minimum (in years)	10 years
Tradename [Member] \| Minimum [Member]
Amortizable intangible assets, useful life, minimum (in years)	1 year
Tradename [Member] \| Maximum [Member]
Amortizable intangible assets, useful life, minimum (in years)	4 years
Patents [Member]
Amortizable intangible assets, useful life, minimum (in years)	5 years

Goodwill and Intangible Assets,

Goodwill and Intangible Assets, Intangible Assets (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016	Sep. 24, 2016	Jun. 25, 2016
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	$ 578,519		$ 578,519			$ 546,919
Accumulated Amortization	474,538		474,538			431,979
Net	103,981		103,981			114,940
Intangible Assets, Gross	578,519		578,519			578,519
Total purchased intangible assets	103,981		103,981			146,540
Cost of goods sold, amortization	11,064	$ 11,829	35,420	$ 43,201
Amortization of Intangible Assets	2,348	2,538	7,139	9,667
Intangible Asset Amortization Expense	13,412	$ 14,367	42,559	$ 52,868
Future amortization expense [Abstract]
Remaining three months of 2017	13,114		13,114
2,018	48,146		48,146
2,019	19,861		19,861
2,020	9,942		9,942
2,021	8,154		8,154
2,022	2,563		2,563
Thereafter	2,201		2,201
Net	103,981		103,981			114,940
Intellectual property [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	451,885		451,885			420,285
Accumulated Amortization	366,741		366,741			331,321
Net	85,144		85,144			88,964
Future amortization expense [Abstract]
Net	85,144		85,144			88,964
Customer relationships [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	115,634		115,634			115,634
Accumulated Amortization	98,293		98,293			92,744
Net	17,341		17,341			22,890
Future amortization expense [Abstract]
Net	17,341		17,341			22,890
Tradename [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	8,500		8,500			8,500
Accumulated Amortization	7,686		7,686			6,486
Net	814		814			2,014
Future amortization expense [Abstract]
Net	814		$ 814			2,014
Patents [Member]
Finite and Indefinite Lived Intangible Assets [Line Items]
Amortizable intangible assets, useful life, minimum (in years)			5 years
Intangible Assets, Net (Excluding Goodwill) [Abstract]
Original Cost	2,500		$ 2,500			2,500
Accumulated Amortization	1,818		1,818			1,428
Net	682		682			1,072
Future amortization expense [Abstract]
Net	682		682			1,072
In Process Research and Development [Member]
Intangible Assets, Net (Excluding Goodwill) [Abstract]
IPR&D	$ 0		$ 0		$ 31,600	$ 31,600

Impairment of Long-Lived Asse54

Impairment of Long-Lived Assets (Details) - USD ($) $ in Thousands	3 Months Ended					9 Months Ended		12 Months Ended
	Mar. 25, 2017	Sep. 24, 2016	Mar. 26, 2016	Dec. 26, 2015	Sep. 26, 2015	Mar. 25, 2017	Mar. 26, 2016	Jun. 25, 2016
Long Lived Assets Held-for-sale [Line Items]
Impairment of long-lived assets	$ 1,000		$ 506			$ 7,517	$ 160,153
Impairment of Long-Lived Assets to be Disposed of					$ 157,700	797	160,153	$ 160,600
Proceeds from Sale of Other Property, Plant, and Equipment						0	40,000
Gain (Loss) on Disposition of Property Plant Equipment						(9,359)	2,765
Proceeds from Divestiture of Businesses						42,199	105,000
Gain (Loss) on Disposition of Business						$ 26,620	$ 58,944
MEMS [Member]
Long Lived Assets Held-for-sale [Line Items]
Proceeds from Sale of Other Property, Plant, and Equipment		$ 42,200
Gain (Loss) on Disposition of Property Plant Equipment		26,600
wafter manufacturing fab [Member]
Long Lived Assets Held-for-sale [Line Items]
Proceeds from Sale of Other Property, Plant, and Equipment		30,000
Gain (Loss) on Disposition of Property Plant Equipment		1,600
Inventory on hand [Member]
Long Lived Assets Held-for-sale [Line Items]
Proceeds from Sale of Other Property, Plant, and Equipment		10,000
San Jose Wafer Fab [Member]
Long Lived Assets Held-for-sale [Line Items]
Proceeds from Sale of Other Property, Plant, and Equipment				$ 39,000
Gain (Loss) on Disposition of Property Plant Equipment				$ 3,800
Energy Metering Business [Member]
Long Lived Assets Held-for-sale [Line Items]
Gain (Loss) on Disposition of Business		$ 58,900

Restructuring Activities (Detai

Restructuring Activities (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended			9 Months Ended			12 Months Ended
	Mar. 25, 2017		Mar. 26, 2016	Mar. 25, 2017		Mar. 26, 2016	Jun. 25, 2016
Restructuring Cost and Reserve [Line Items]
Operating Income (Loss)	$ 174,252		$ 177,708	$ 495,399		$ 191,476
Restructuring Reserve [Roll Forward]
Net income	$ 140,213		$ 139,810	$ 408,304		$ 135,136
Earnings per share, Basic (per share)	$ 0.50		$ 0.49	$ 1.44		$ 0.47
Earnings per share, Diluted	$ 0.49		$ 0.48	$ 1.42		$ 0.47
San Jose Fab Shutdown Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring and Related Cost, Cost Incurred to Date							$ 100,300
Other Restructuring Plans [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve				$ 7,578
Severance and restructuring expenses				11,912
Payments for Restructuring				(13,829)
Restructuring Reserve, Accrual Adjustment				(633)
Restructuring Reserve	$ 5,028	[1]		5,028	[1]		7,578
WLP Accelerated Depreciation [Member]
Restructuring Reserve [Roll Forward]
Severance and restructuring expenses	1,100			4,200
WLP Accelerated Depreciation [Member] \| Other Restructuring Plans [Member]
Restructuring Reserve [Roll Forward]
Severance and restructuring expenses							13,000
Accelerated Depreciation [Member] \| San Jose Fab Shutdown Plan [Member]
Restructuring Reserve [Roll Forward]
Severance and restructuring expenses							41,600
Employee Severance [Member] \| San Jose Fab Shutdown Plan [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charge, Charges and Change in Estimates							400
Employee Severance [Member] \| Other Restructuring Plans [Member]
Restructuring Cost and Reserve [Line Items]
Restructuring Charge, Charges and Change in Estimates	500			11,300			$ 24,000
Service Life [Member]
Restructuring Cost and Reserve [Line Items]
Operating Income (Loss)	(1,103)		$ (4,481)	(4,225)		$ (50,145)
Operating Income (Loss), Excluding Accelerated Depreciation Expense	175,355		182,189	499,624		241,621
Restructuring Reserve [Roll Forward]
Net income	(908)		(5,838)	(3,747)		(48,216)
Net Income (Loss), Excluding Accelerated Depreciation Expense	$ 141,121		$ 145,648	$ 412,051		$ 183,352
Earnings per share, Basic (per share)	$ 0.50		$ 0.51	$ 1.45		$ 0.64
Earnings per share, Diluted	0.49		0.50	1.43		0.63
Decrease in basic earnings per share	0		(0.02)	(0.01)		(0.17)
Decrease in Diluted Earnings Per Share	$ 0		$ (0.02)	$ (0.01)		$ (0.16)

[1]	Charges and change in estimates are included in Severance and restructuring expenses in the accompanying Condensed Consolidated Statements of Income.

Restructuring Activities Change

Restructuring Activities Change in Estimate (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Mar. 25, 2017	Mar. 26, 2016	Mar. 25, 2017	Mar. 26, 2016
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ 174,252	$ 177,708	$ 495,399	$ 191,476
Net income	$ 140,213	$ 139,810	$ 408,304	$ 135,136
Basic (per share)	$ 0.50	$ 0.49	$ 1.44	$ 0.47
Diluted (per share)	$ 0.49	$ 0.48	$ 1.42	$ 0.47
Service Life [Member]
Change in Accounting Estimate [Line Items]
Operating Income (Loss)	$ (1,103)	$ (4,481)	$ (4,225)	$ (50,145)
Operating Income (Loss), Excluding Accelerated Depreciation Expense	175,355	182,189	499,624	241,621
Net income	(908)	(5,838)	(3,747)	(48,216)
Net Income (Loss), Excluding Accelerated Depreciation Expense	$ 141,121	$ 145,648	$ 412,051	$ 183,352
Basic (per share)	$ 0.50	$ 0.51	$ 1.45	$ 0.64
Diluted (per share)	0.49	0.50	1.43	0.63
Decrease in basic earnings per share	0	(0.02)	(0.01)	(0.17)
Decrease in Diluted Earnings Per Share	$ 0	$ (0.02)	$ (0.01)	$ (0.16)